Title: Comparison of Liver Enzymes (ALT, AST & GGT) in Patients with Newly Diagnosed and Established Type-2 Diabetes Mellitus in Rural Population of Northern India
Authors: Manju Pandey, Gajraj Singh Yadav, Moharkar Sharad Namdeo, Ganpat Devpura
DOI: https://dx.doi.org/10.18535/jmscr/v7i1.136
Abstract
References
Background: Work on the comparison of liver enzymes between newly diagnosed type-2 diabetes mellitus (T2DM) and established T2DM can be an indicator of insulin resistance.
Objective: To compare the serum levels of alanine amino transferase (ALT), aspartate amino transferase (AST), and γ-glutamyle transferase (GGT) in patients with newly diagnosed and established T2DM in rural Jaipur (India).
Material and Methods: A cross-sectional study comprises with 240 subjects, divided into three groups of 80 each including control. (a): 80-newly diagnosed type-2 DM, (b): 80-established T2DM and (c): 80-healthy age and sex matched controls. Fully automated analyser (HUMAN) was used for biochemical analysis of FPG, ALT, AST, GGT. Chi square (χ2) test and Z-test were used for statistical analysis. P<0.05 was considered as significant.
Results: Highly significant association was found between newly diagnosed T2DM with raised ALT/ raised GGT, and no significant association was found between newly diagnosed T2DM and raised AST with compare to established T2DM.
Conclusion: Rise of ALT and GGT in newly diagnosed T2DM represents insulin resistance due to accumulation of fat in hepatocytes and indicates more oxidative stress due to lipid per-oxidation, β-oxidation. Rise in AST is nonspecific to liver involvement in T2DM and might be due to other manifestations.
Keywords: Liver enzymes ALT, AST, GGT, T2DM.
- Mittendorfer B, Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking. Current opinion in clinical nutition and metabolic care. 2011;14(6):535-40.
- Mohan V, Sandeep S, Deepa R, Dhah B, Varghees C. Epidemiology of type 2 diabetes : Indian India journal of medical research. 2007;125(3):217-21.
- Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility toal coholicsteatohepatitis. Hepatology. 1997; 26(1):143-46.
- Nguyen QM, Srinivasan SR, XuJH, ChenW, Hassing S, Rice J, et al. Elevated liver function enzyme are related to the development of prediabetes and type 2 diabetes in younger adults the Bogalusa heart study. Diabetes care. 2011; 34(12):2603-07.
- Salmela PI, Sotaniemi EA, Niemi M, Maentausta O. Liver function tests in diabetic patients. Diabetes care.1984; 7(3):248-54.
- Harris EH. Elevated liver function tests in type 2 diabetes. Clinical diabetes.2005; 23(3):115-19.
- Trinder P, Determination of glucode using an oxidaseperoxidase system with a non-carcinogenic chromogen. Journal of Clinical Pathology.1969;22:158-61.
- Saligram S, Williums EJ, Masding MG, Raised liver enzymes in newly diagnosed type 2 diabetes are associated with weight and lipids, but not glycemic control. Indian journal of endocrinology and metabolism 2012;16(6):1012-14.
- Sattar N, Acherbakova O, Ford I, O’Reilly DS, Stanely A, Forrest E, et al. Elevated alanine aminotransterase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes.2004;53(11):2855-60.
- Ahn HR, Shin MH, Nam HS, Park KS, LeeYH, Jeong SK, et al. The association between liver enzymes and risk of type 2 diabetes: the Namwon study. Diabetology & metabolic syndrome. 2014; 6(14):1-8.
- Sabanayagam C, Shankar A, Li J, Pollard C, Ducatman A. Serum gamma-glutamyl transferase level and diabetes mellitus among US adults. European joural of epidemiology. 2009; 24(7):369-73.